We believe further in vitro studies as well as time-point experiments on aggregate formation in vivo will be beneficial to our understanding of the precise contribution of the Hsp70–Hsp40–Hsp110 system in prion diseases and prion-like protein misfolding diseases. This evidence concerns the gene HSPA4 and proteostasis deficiencies.